Cefazolin sodium labels and packages: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
mNo edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}} {{SS}}
{{CMG}}; {{AE}} {{SS}}


==Labels And Packages==
==Labels and Packages==


{|
{|
Line 27: Line 27:
|[[File:Cefazolin 8.jpg|thumb|400px|left]]
|[[File:Cefazolin 8.jpg|thumb|400px|left]]
|-
|-
|}<ref>{{Cite web | last = |first =|title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf |publisher =|date = | accessdate = }}</ref>
|}
 
 
==References==
{{Reflist}}


{{FDA}}
{{FDA}}

Latest revision as of 00:34, 6 January 2014

Cefazolin Sodium
CEFAZOLIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
Compatibility, Reconstitution, and Stability
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels and Packages

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Cefazolin_sodium_labels_and_packages&oldid=925364"